Mikhail Byakhow
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
Papers in
- Oncology 2
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 2
- Co-authors
- Milvia Zambetti (2 shared papers)Federico Vázquez (2 shared papers)José Baselga (2 shared papers)W. Eiermann (2 shared papers)Luca Gianni (2 shared papers)Semiglazov Vf (2 shared papers)S. Tjulandin (1 shared paper)A. Feyereislova (1 shared paper)
- Partner nations
- SpainSwitzerlandItaly
In The Last Decade
Mikhail Byakhow
2 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 51
- Cancer Research 624
- Oncology 875
- Radiology, Nuclear Medicine and Imaging 309
- Pathology and Forensic Medicine 125
- Pulmonary and Respiratory Medicine 155
Countries citing papers authored by Mikhail Byakhow
This map shows the geographic impact of Mikhail Byakhow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Byakhow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Byakhow more than expected).
Fields of papers citing papers by Mikhail Byakhow
This network shows the impact of papers produced by Mikhail Byakhow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Byakhow. The network helps show where Mikhail Byakhow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mikhail Byakhow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort Hit paper breakdown → | 2010 | 891 |
| 2 | 2014 | 158 |
About Mikhail Byakhow
Mikhail Byakhow is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 2 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Monoclonal and Polyclonal Antibodies Research (1 paper) and Breast Lesions and Carcinomas (1 paper). The work is most often cited by research in Cancer Research (624 citations), Oncology (875 citations), Radiology, Nuclear Medicine and Imaging (309 citations), Pathology and Forensic Medicine (125 citations) and Pulmonary and Respiratory Medicine (155 citations). Mikhail Byakhow has collaborated with scholars based in Spain, Switzerland and Italy. Frequent co-authors include Milvia Zambetti, Federico Vázquez, José Baselga, W. Eiermann, Luca Gianni, Semiglazov Vf, S. Tjulandin, A. Feyereislova, Mikhail Lichinitser and Pinuccia Valagussa. Their work appears in journals such as Clinical Cancer Research and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.